ICH Q1: A Consolidated Framework for Stability Testing of Biologics
Last year, a long-anticipated change finally happened for stability [...]
Cannabinoid Bioanalysis: A Validated Multi-Analyte LC-MS/MS Method in Human Plasma
The growing interest in cannabinoid-based therapies has led to [...]
One-Stop-Shop solutions for Preclinical, Animal Health, Bioequivalence, and Clinical Studies
Developing new medicines or demonstrating the equivalence of generic products [...]
Kymos Group expands with the acquisition of Particle Analytical
Kymos Group continues to expand its European footprint and scientific [...]
Kymos Group celebrates 25 years #SupportingScience
Official Press Release Kymos Group, a European CRO & CLO [...]
USP <665>/<1665>: Extractables & Leachables in Single-Use-Systems
Single-use systems (SUS) have become an integral part of modern [...]
Biosimilar Development: From Phase III to Analytical Comparability and PK/PD
Although the development of biosimilars has historically been difficult, [...]
OligoXplorer: Our CMC Platform for Oligonucleotide Therapeutics
Oligonucleotide-based therapeutics have become one of the most promising [...]